ScholarIQanswers from OpenAlex & ORCID
Michael Baum
ResearcherPublications, citations & collaboration network
Michael Baum is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Michael Baum have?
ScholarIQindexed works
Michael Baum has 540 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Michael Baum have?
ScholarIQcitation count
Michael Baum has 21,087 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Michael Baum?
ScholarIQh-index
Michael Baum has an h-index of 64 in OpenAlex.
What is the i10-index of Michael Baum?
ScholarIQi10-index
Michael Baum has an i10-index of 220 in OpenAlex.
What is the ORCID of Michael Baum?
ScholarIQorcid
The ORCID for Michael Baum is on the source record.
What is the OpenAlex record for Michael Baum?
ScholarIQopenalex
The OpenAlex for Michael Baum is on the source record.
What are the most-cited papers on Michael Baum?
ScholarIQmost cited works
Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial
Jayant S. Vaidya, Frederik Wenz, Max Bulsara, Jeffrey Tobias, David Joseph, Mohammed Keshtgar, Henrik Flyger, Samuele Massarut, Michael Alvarado, Christobel Saunders, W. Eiermann, Marinos Metaxas, Elena Sperk, Marc Sütterlin, Douglas Brown, Laura J. Esserman, Mario Roncadin, Alastair M. Thompson, John Dewar, Helle Holtveg, Steffi Pigorsch, Mary Falzon, Eleanor Harris, April Matthews, Chris Brew‐Graves, Ingrid Potyka, Tammy Corica, Norman Williams, Michael Baum
Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial
Jayant S. Vaidya, David Joseph, Jeffrey Tobias, Max Bulsara, Frederik Wenz, Christobel Saunders, Michael Alvarado, Henrik Flyger, Samuele Massarut, W. Eiermann, Mohammed Keshtgar, John Dewar, Uta Kraus-Tiefenbacher, Marc Sütterlin, Laura J. Esserman, Helle Holtveg, Mario Roncadin, Steffi Pigorsch, Marinos Metaxas, Mary Falzon, April Matthews, Tammy Corica, Norman Williams, Michael Baum
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial
Jayant S. Vaidya, Max Bulsara, Michael Baum, Frederik Wenz, Samuele Massarut, Steffi Pigorsch, Michael Alvarado, Michael Douek, Christobel Saunders, Henrik Flyger, W. Eiermann, Chris Brew‐Graves, Norman Williams, Ingrid Potyka, Nicholas Roberts, Marcelle Bernstein, Douglas Brown, Elena Sperk, Siobhan Laws, Marc Sütterlin, Tammy Corica, Steinar Lundgren, Dennis R. Holmes, Lorenzo Vinante, Fernando A. Bozza, Montserrat Pazos, Magali Le Blanc‐Onfroy, Günther Gruber, Wojciech Polkowski, Konstantin J. Dedes, Marcus Niewald, Jens‐Uwe Blohmer, David R. McCready, Richard Hoefer, Pond R. Kelemen, Gloria Petralia, Mary Falzon, David Joseph, Jeffrey Tobias